Aurinia Pharmaceuticals Inc (AUPH)
PHARMACEUTICAL PREPARATIONS
Aurinia Pharmaceuticals Inc (AUPH) is listed on Nasdaq, where it has traded since October 21, 2009.
- Listed On
- Nasdaq
- Listed Since
- October 21, 2009
- Employees
- 128
- Market Cap
- $2.3B
About Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 273 institutions reported holding AUPH, with 78.0 million shares worth $1.3 billion in aggregate. The largest reported holder was Tang Capital Management, with 13.0 million shares worth $221.4 million. Of the 5 largest holders listed below, 4 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Tang Capital Management | 13,044,106 | $221M | Added 6.66% |
| BlackRock | 8,193,085 | $139M | Added 4.43% |
| Goldman Sachs | 5,619,401 | $95M | Added 292% |
| Nea Management Company | 3,969,834 | $67M | Unchanged |
| Two Sigma Investments | 3,467,514 | $59M | Added 1.13% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is AUPH?
Aurinia Pharmaceuticals Inc (AUPH) is listed on Nasdaq, where it has traded since October 21, 2009.
Who are the largest institutional holders of AUPH?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AUPH were Tang Capital Management, BlackRock and Goldman Sachs.
How many institutions own AUPH?
273 institutions reported a position in AUPH for the quarter ended June 30, 2026, worth $1.3 billion in total.
Did institutions buy or sell AUPH last quarter?
Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for AUPH.
Every reported institutional holder, plus insider and congressional trades in AUPH, on SentiSense.